EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H30O2 |
| Net Charge | 0 |
| Average Mass | 314.469 |
| Monoisotopic Mass | 314.22458 |
| SMILES | [H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)Oc1cc(CCCCC)cc(O)c12 |
| InChI | InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1 |
| InChIKey | CYQFCXCEBYINGO-IAGOWNOFSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Cannabis sativa (ncbitaxon:3483) | aerial part (BTO:0001658) | PubMed (21902175) | Acetone extract of Dried, powdered and heated flowered aerial parts |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. cannabinoid receptor agonist An agonist that binds to and activates cannabinoid receptors. |
| Applications: | antirheumatic drug A drug used to treat rheumatoid arthritis. antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. anti-inflammatory agent Any compound that has anti-inflammatory effects. antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. hypoglycemic agent A drug which lowers the blood glucose level. appetite enhancer A drug which increases appetite. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. hallucinogen Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations and other alterations of mood and thinking. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role analgesic (CHEBI:35480) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role anti-anaemic agent (CHEBI:75835) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role anti-HIV agent (CHEBI:64946) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role anti-inflammatory agent (CHEBI:67079) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antidepressant (CHEBI:35469) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antiemetic (CHEBI:50919) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antineoplastic agent (CHEBI:35610) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antipsychotic agent (CHEBI:35476) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antirheumatic drug (CHEBI:35842) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antispasmodic drug (CHEBI:53784) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role appetite enhancer (CHEBI:50779) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role cannabinoid receptor agonist (CHEBI:67072) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role epitope (CHEBI:53000) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role hallucinogen (CHEBI:35499) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role hypoglycemic agent (CHEBI:35526) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role immunosuppressive agent (CHEBI:35705) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role metabolite (CHEBI:25212) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role non-narcotic analgesic (CHEBI:35481) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a benzochromene (CHEBI:38920) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a diterpenoid (CHEBI:23849) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a phytocannabinoid (CHEBI:67196) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) is a polyketide (CHEBI:26188) |
| Incoming Relation(s) |
| 11-hydroxy-Δ9-tetrahydrocannabinol (CHEBI:77270) has functional parent Δ9-tetrahydrocannabinol (CHEBI:66964) |
| 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (CHEBI:77273) has functional parent Δ9-tetrahydrocannabinol (CHEBI:66964) |
| IUPAC Name |
|---|
| (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol |
| INN | Source |
|---|---|
| dronabinol | KEGG DRUG |
| Synonyms | Source |
|---|---|
| 1-trans-delta-9-Tetrahydrocannabinol | ChemIDplus |
| 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol | ChemIDplus |
| 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | NIST Chemistry WebBook |
| ABBOTT 40566 | ChEMBL |
| ABBOTT-40566 | ChEMBL |
| .delta.1-thc | ChEMBL |
| Brand Names | Source |
|---|---|
| Dronabinol component of ad-313 | ChEMBL |
| Dronabinol component of ad313 | ChEMBL |
| Dronabinol component of sci-110 | ChEMBL |
| Syndros | ChEBI |
| UniProt Name | Source |
|---|---|
| Δ9-tetrahydrocannabinol | UniProt |
| Manual Xrefs | Databases |
|---|---|
| 4109 | DrugCentral |
| C00002675 | KNApSAcK |
| C06972 | KEGG COMPOUND |
| CPD-7172 | MetaCyc |
| D00306 | KEGG DRUG |
| DB00470 | DrugBank |
| HMDB0041865 | HMDB |
| TCI | PDBeChem |
| Tetrahydrocannabinol | Wikipedia |
| Citations |
|---|